FDA Using Medicare Data Linked to NCI Databases to Look at Cancer Signals

 
• By Laura Helbling

FDA is looking at linking Medicare data to National Cancer Institute registries to enhance the information from medical claims data and gain a better understanding of disease-cancer and drug-cancer relationships. A familiar figure from FDA epidemiological work is keenly involved: safety officer David Graham.

FDA Office of Pharmacovigilance & Epidemiology Associate Director for Science and Medicine David Graham is digging back into the Medicare database to check for relationships between drug use and the incidence of cancer.

The starting point for his investigation into new linked database sources is familiar: diabetes and pancreatic cancer. Graham was very publicly associated with an examination of Medicare data for evidence of a different set of side effects (cardiovascular) associated with the GlaxoSmithKline PLC drug Avandia in 2010

More from Archive

More from Pink Sheet